berberine has been researched along with indomethacin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, Y; Feng, F; Guo, Q; He, S; Liu, W; Liu, Y; Sun, H; Zhao, L | 1 |
| Barna, I; Haller, J; Kovács, JL | 1 |
| Chi, CW; Kuo, CL; Liu, TY | 1 |
| Fukutake, M; Imoto, S; Ishige, A; Miura, N; Miyano, S; Nagasaki, M; Saito, A; Takeda, J; Watanabe, K; Watanabe-Fukuda, Y; Yamaguchi, R; Yamamoto, M | 1 |
| Chen, H; Lai, X; Li, C; Lin, G; Luo, C; Su, Z; Tan, L; Wang, Y; Xie, J; Zeng, H | 1 |
| Cheng, Y; Ji, Y; Ouyang, D | 1 |
1 review(s) available for berberine and indomethacin
| Article | Year |
|---|---|
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Binding Sites; Cell Proliferation; Clinical Trials as Topic; Drug Development; Drug Resistance, Neoplasm; Humans; Models, Molecular; Molecular Structure; Neoplasms; Treatment Outcome | 2020 |
7 other study(ies) available for berberine and indomethacin
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Alpha 2-adrenoceptor blockade, pituitary-adrenal hormones, and agonistic interactions in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Agonistic Behavior; Animals; Berberine; Corticosterone; Dioxanes; Dose-Response Relationship, Drug; Idazoxan; Indomethacin; Male; Pituitary-Adrenal System; Rats; Social Behavior; Yohimbine | 1994 |
The anti-inflammatory potential of berberine in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Indomethacin; Isoenzymes; Membrane Proteins; Mouth Neoplasms; Prostaglandin-Endoperoxide Synthases; Protein Binding; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Time Factors; Transcription Factor AP-1; Up-Regulation | 2004 |
Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Drugs, Chinese Herbal; Female; Gene Expression Profiling; Indomethacin; Intestinal Diseases; Intestine, Small; Mice; Mice, Inbred BALB C | 2009 |
Protective effect of coptisine free base on indomethacin-induced gastric ulcers in rats: Characterization of potential molecular mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Berberine; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Gastric Mucosa; Indomethacin; Interleukin-1beta; Lansoprazole; Male; p38 Mitogen-Activated Protein Kinases; Rats; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
FC-BBR/IND-induced glucose oxidase nanodrugs for targeted combination therapy.
Topics: Antineoplastic Agents; Berberine; Cell Cycle Checkpoints; Glucose Oxidase; Hep G2 Cells; Humans; Indomethacin; Membrane Potential, Mitochondrial; Metallocenes; Nanomedicine; Reactive Oxygen Species | 2022 |